The $2 Trillion Valuation Debate Skips What Anthropic Knows
Pharmacore secures funding to improve medication regimen reviews in long-term care
New ESW Guide Explains Copilot Studio Agent Pricing and the Controls to Set First
EMH Group modernises resident WiFi across its estate with Purple
TestMu AI Launches New Experience in KaneAI, Turning Recorded Tests into Objectives That Repair Themselves
CHICAGO–(BUSINESS WIRE)–The AZEK Company Inc. (NYSE: AZEK) (“AZEK” or the “Company”), the industry-leading manufacturer of…
Company announcement – No. 36 / 2023 Total number of shares and voting rights in…
HARTLAND, Wis.–(BUSINESS WIRE)–Fathom Digital Manufacturing Corp. (“Fathom” or the “Company”) (NYSE: FATH), an industry leader…
Divestment includes Xiidra®, on-market treatment for dry eye disease and additional ophthalmic investigational therapies Novartis…
Proof-of-concept data supports the clinical evaluation of the Cell Pouch System as a potential treatment…
The combined company aims to accelerate precision, personalized medicine for longevity powered by mutually reinforcing…
Toronto, Ontario–(Newsfile Corp. – September 29, 2023) – Deveron Corp. (TSXV: FARM) is pleased to…
BROOKLYN HEIGHTS, Ohio–(BUSINESS WIRE)–GrafTech International Ltd. (NYSE:EAF) (“GrafTech” or the “Company”) announced today that Marcel…
Company Appoints Ed Grabscheid as new CFO, Jacob Shulman to depart as CFO at Fiscal…
NEWCASTLE & HOUSTON–(BUSINESS WIRE)–TechnipFMC (NYSE: FTI) has been awarded a significant(1) contract to supply flexible…
NEW YORK–(BUSINESS WIRE)–New Mountain Finance Corporation (Nasdaq: NMFC) (“New Mountain” or “the Company”) announced today…
DEVON, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
DEVON, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
If approved, odronextamab would be the first and only bispecific antibody approved in both FL…
If approved, odronextamab would be the first and only bispecific antibody approved in both FL…
JUPITER, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
JUPITER, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
ISELIN, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical…
ISELIN, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical…
WESTPORT, Conn., Sept. 29, 2023 (GLOBE NEWSWIRE) — Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage…